JP2025511331A5 - - Google Patents

Info

Publication number
JP2025511331A5
JP2025511331A5 JP2024558382A JP2024558382A JP2025511331A5 JP 2025511331 A5 JP2025511331 A5 JP 2025511331A5 JP 2024558382 A JP2024558382 A JP 2024558382A JP 2024558382 A JP2024558382 A JP 2024558382A JP 2025511331 A5 JP2025511331 A5 JP 2025511331A5
Authority
JP
Japan
Prior art keywords
crystalline
amg176
xrpd pattern
radiation
pattern peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511331A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/017505 external-priority patent/WO2023196361A1/en
Publication of JP2025511331A publication Critical patent/JP2025511331A/ja
Publication of JP2025511331A5 publication Critical patent/JP2025511331A5/ja
Pending legal-status Critical Current

Links

JP2024558382A 2022-04-05 2023-04-05 Ｍｃｉ－１アンタゴニストの非晶質及び結晶性形態 Pending JP2025511331A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263327656P 2022-04-05 2022-04-05
US63/327,656 2022-04-05
PCT/US2023/017505 WO2023196361A1 (en) 2022-04-05 2023-04-05 Amorphous and crystalline forms of mci-1 antagonists

Publications (2)

Publication Number Publication Date
JP2025511331A JP2025511331A (ja) 2025-04-15
JP2025511331A5 true JP2025511331A5 (enExample) 2026-04-10

Family

ID=86386948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558382A Pending JP2025511331A (ja) 2022-04-05 2023-04-05 Ｍｃｉ－１アンタゴニストの非晶質及び結晶性形態

Country Status (9)

Country Link
US (1) US20240140966A1 (enExample)
EP (1) EP4504738A1 (enExample)
JP (1) JP2025511331A (enExample)
AU (1) AU2023250874A1 (enExample)
CA (1) CA3255077A1 (enExample)
MX (1) MX2024012195A (enExample)
TW (1) TW202404982A (enExample)
UY (1) UY40218A (enExample)
WO (1) WO2023196361A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4519271A1 (en) 2022-05-04 2025-03-12 Gilead Sciences, Inc. Salts and polymorphs of certain mcl-1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3474B1 (ar) 2014-08-29 2020-07-05 Amgen Inc مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1
KR20230113577A (ko) * 2020-11-25 2023-07-31 암젠 인크 알데히드의 거울상이성질체 선택적 알케닐화

Similar Documents

Publication Publication Date Title
JP2022526438A5 (enExample)
JP2022049005A5 (enExample)
RU2014110399A (ru) Кристаллические формы вгс протеазного ингибитора
RU2012138892A (ru) СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА
CA2687927A1 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
CN102675380A (zh) 结晶型1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯半水合物
KR102612379B1 (ko) 벤조푸란 유도체 자유 염기의 결정 및 제조 방법
JP2022534788A5 (enExample)
JP2005520819A5 (enExample)
US11028069B2 (en) Salt of substituted piperidine compound
JP2025511331A5 (enExample)
JP2023027066A5 (enExample)
JP2020536893A5 (enExample)
EA004809B1 (ru) 5-хлор-3(4-метансульфонилфенил)-6'-метил-[2,3']бипиридинил в чистой кристаллической форме и способ синтеза
HK1044768A1 (en) Crystalline 1-methylcarbapenem compounds
JP2023530785A5 (enExample)
RU2021132394A (ru) Кристаллическая фумаратная соль (s)-[3,4-дифтор-2-(2-фтор-4-йодфениламино)фенил][3-гидрокси-3-(пиперидин-2-ил)азетидин-1-ил]метанона
RU2009119411A (ru) Новые кристаллические формы
JP2024001040A5 (enExample)
JP2025505141A5 (enExample)
JP2023524518A5 (enExample)
JP2025513774A5 (enExample)
KR20060049966A (ko) 스트론티움 라넬레이트의 알파 결정형, 이의 제조방법, 및이를 함유하는 약제 조성물
JP2005529084A5 (enExample)
JP2023518419A5 (enExample)